Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

DNA test for all babies to study disease risk

Screening newborn babies for rare diseases will involve sequencing their complete DNA

Screening newborn babies for rare diseases will involve sequencing their complete DNA

iStock

Key Summary

  • The DNA of newborn babies will be sequenced using blood samples from their umbilical cord
  • The government will invest £650m in DNA research for all patients by 2030
  • Genomics and AI would be used for faster diagnoses

Children born in England will have their DNA mapped to screen for hundreds of diseases under the NHS plan for the next 10 years.


Health secretary Wes Streeting told The Telegraph that the Labour government plans to move the NHS towards a model of sickness prevention from sickness treatment.

The government will invest £650m in DNA research for all patients by 2030 and personalised medicine will form a big part of that plan.

He said genomics will help us "to leapfrog disease, so we're in front of it rather than reacting to it."

The Department for Health and Social Care said that genomics and AI would be used for faster diagnoses.

Screening newborn babies for rare diseases will involve sequencing their complete DNA using blood samples from their umbilical cord, taken shortly after birth.

At present, the newborns are offered a blood test to check for nine rare but serious conditions.

Streeting claimed this will transform the NHS "from a service which diagnoses and treats ill-health to one that predicts and prevents it."

The Government's 10-year plan also includes the NHS moving care away from hospitals to communities, and from analogue to digital services.

More For You

Home cervical screening kits in England

Government data states that around five million women are still not attending cervical screenings

Getty Images

Home cervical screening kits launched in England

Key Summary

  • NHS England has launched at-home cervical screening kits to improve uptake among women aged 25 to 64.
  • The discreet kits aim to overcome barriers like embarrassment and increase screening rates from 68.8 per cent towards the 80 per cent target.
  • Early diagnosis through home testing is expected to boost survival rates and help tackle cervical cancer for all communities.

NHS England has created an innovative at-home human papillomavirus (HPV) testing, for women who are yet to take cervical screening service.

Keep ReadingShow less
NHS warns doctors using unapproved  AI Software

NHS England has demanded that GPs and hospitals stop using artificial intelligence software that could breach data protection rules.

iStock

NHS warns doctors against use of unapproved AI software

Key Summary

  • NHS wants GPs and hospitals to stop using dubious artificial intelligence software during patient meetings
  • It had in April urged the doctors to use AI for notetaking using Ambient Voice Technology software
  • But it now claims that many AVT suppliers, who fail to meet NHS governance standards, are selling them to doctors
  • British Medical Association officials want the NHS to help doctors choose the safe AVT software

Doctors have been warned against the use of AI software that does not meet minimum standards to record and transcribe patient meetings.

Keep ReadingShow less
Mother holding newborn baby during early postnatal care in NHS maternity setting

Mother with newborn in NHS maternity care

Getty Images

Failing maternity services leads to nation-wide inquiry

Key Summary
  • Wes Streeting has ordered a national inquiry into failing NHS maternity and neonatal services
  • The review will start this summer, focusing first on the worst-performing units
  • A second phase will examine the entire system and propose national improvements
  • The inquiry will tackle racial inequalities and maternity mortality disparities

Health Secretary Wes Streeting has commissioned a nation-wide inquiry due to the rise in the number of failing maternity and neonatal services in the country.

NHS trusts such as Morecambe Bay, Shrewsbury and Telford, East Kent, Nottingham and Leeds are some of the names on the worst-performing list.

Keep ReadingShow less
UK globally competitive in life sciences

The Industrial Strategy has identified eight high-growth potential sectors, including life sciences.

iStock

Key test will be to make UK globally competitive in life sciences: ABPI

Key Summary

  • The Industrial Strategy has identified life sciences as one of its high-growth potential sectors
  • ABPI wants the UK to become a leading centre for life sciences research and development
  • It wants the government to move quickly from planning to delivery

The Association of the British Pharmaceutical Industry (ABPI) has welcomed the government’s new Industrial Strategy, but said the key test for life sciences will be whether it can return the UK to international competitiveness.

Keep ReadingShow less
Uneven HPV vaccine uptake increases cervical cancer risk: UKHSA

UKHSA data shows that the uptake of the HPV vaccines for boys and girls was the lowest in London and highest in the south-east.

iStock

Uneven HPV vaccine uptake increases cervical cancer risk: UKHSA

The UK Health Security Agency (UKHSA) has warned that variations in geographical coverage of Human Papillomavirus (HPV) vaccine in adolescents across England is leaving many with less protection against cervical and some other cancers.

Data provided by Cancer Research UK indicates that cervical cancer rates in England are 65 per cent higher in the most deprived quintile compared with the least.

Keep ReadingShow less